Li-Fraumeni syndrome in a Malaysian kindred

Cancer Genetics and Cytogenetics

Volumn 186, Issue 1, 2008, Pages 49-53

  Ariffin, Hany ^a   Martel Planche, Ghyslaine ^b   Daud, Siti Sarah ^a   Ibrahim, Kamariah ^a   Hainaut, Pierre ^b  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CASE REPORT; EMBRYONAL RHABDOMYOSARCOMA; FAMILIAL CANCER; FEMALE; GENE DUPLICATION; GENE MUTATION; HUMAN; INFANT; MALAYSIA; MALE; NUCLEOTIDE SEQUENCE; PEDIGREE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADRENAL CORTEX NEOPLASMS; ADULT; BREAST NEOPLASMS; CARCINOMA; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; FEMALE; GENES, P53; HUMANS; INFANT; LI-FRAUMENI SYNDROME; MALAYSIA; MALE; MUTAGENESIS, INSERTIONAL; PEDIGREE; RHABDOMYOSARCOMA, EMBRYONAL; SOFT TISSUE NEOPLASMS;

EID: 50949123760     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.06.004     Document Type: Article

References (19)

1. Li F.P., Fraumeni Jr. J.F., Mulvihill J.J., Blattner W.A., Dreyfus M.G., Tucker M.A., and Miller R.W. A cancer family syndrome in twenty-four kindreds. Cancer Res 48 (1988) 5358-5362
2. Chompret A. The Li-Fraumeni syndrome. Biochimie 84 (2002) 75-82
3. Malkin D., Li F.P., Strong L.C., Fraumeni Jr. J.F., Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., and Tainsky M.A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. [Erratum in: Science 1993;259:878]. Science 250 (1990) 1233-1238
4. Srivastava S., Zou Z.Q., Pirollo K., Blattner W., and Chang E.H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348 (1990) 747-749
5. Hainaut P., and Hollestein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77 (2000) 81-137
6. Birch J.M., Blair V., Kelsey A.M., Evans D.G., Harris M., Tricker K.J., and Varley J.M. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 17 (1998) 1061-1068
7. Olivier M., Eeles R., Hollstein M., Khan M.A., Harris C.C., and Hainaut P. The IARC TP53 database: new online mutation analysis and recommendation to users. Hum Mutat 19 (2002) 607-614
8. International Agency for Research on Cancer. TP53 sequencing methods [Internet]. Available at: http://www-p53.iarc.fr/p53sequencing.html. Accessed January 13, 2008.
9. Achatz M.I., Olivier M., Le Calvez F., Martel-Planche G., Lopes A., Rossi B.M., Ashton-Prolla P., Giugliani R., Palmero E.I., Vargas F.R., Da Rocha J.C., Vettore A.L., and Hainaut P. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett 245 (2007) 96-102
10. Li F.P., Garber J.E., Friend S.H., Strong L.C., Patenaude A.F., Juengst E.T., Reilly P.R., Correa P., and Fraumeni Jr. J.F. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst 84 (1992) 1156-1160
11. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21 (2003) 2397-2406
12. Eeles R.A., Warren W., Knee G., Bartek J., Averill D., Stratton M.R., Blake P.R., Tait D.M., Lane D.P., Easton D.F., et al. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogene 8 (1993) 1269-1276
13. Malkin D., Jolly K.W., Barbier N., Look A.T., Friend S.H., Gebhardt M.C., Andersen T.I., Børresen A.L., Li F.P., Garber J., and Strong L.C. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. [Erratum in: N Engl J Med 1997;336:734]. N Engl J Med 326 (1992) 1309-1315
14. Hisada M., Garber J.E., Fung C.Y., Fraumeni Jr. J.F., and Li F.P. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 90 (1998) 606-611
15. Masciari S., Van den Abbeele A.D., Diller L.R., Rastarhuyeva I., Yap J., Schneider K., Digianni L., Li F.P., Fraumeni J.F., Syngal S., and Garber J.E. F18-Fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA 299 (2008) 1315-1319
16. Horio Y., Suzuki H., Ueda R., Koshikawa T., Sugiura T., Ariyoshi Y., Shimokata K., and Takahashi T. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 9 (1994) 1231-1235
17. Yamada H., Shinmura K., Okudela K., Goto M., Suzuki M., Kuriki K., Tsuneyoshi T., and Sugimura H. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population. Carcinogenesis 28 (2007) 2013-2018
18. Bang Y.J., Kang S.H., Kim T.Y., Jung C.W., Oh S.M., Choe K.J., and Kim N.K. The first documentation of Li-Fraumeni syndrome in Korea. J Korean Med Sci 10 (1995) 205-210
19. Kim I.J., Kang H.C., Shin Y., Park H.W., Jang S.G., Han S.Y., Lim S.K., Lee M.R., Chang H.J., Ku J.L., Yang H.K., and Park J.G. A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J Hum Genet 49 (2004) 591-595